Crimson Publishers Publish With Us Reprints e-Books Video articles


Global Journal of Endocrinological Metabolism

New Insights into Inflammation in Atherosclerosis

  • Open or Close Michael AB Naafs*

    Naafs International Health Consultancy, Europe

    *Corresponding author: Michael AB Naafs, Dutch Internist Endocrinologist, Health Consultant at Naafs International Health Consultancy, Rhodoslaan, Oldenzaal, The Netherlands

Submission: September 10, 2018; Published: September 19, 2018

DOI: 10.31031/GJEM.2018.02.000547

ISSN 2637-8019
Volume2 Issue4


In this mini-review recent developments in the pathogenesis, pathophysiology, biomarkers and therapeutics in residual inflammation of atherosclerosis are discussed. New cellular pathways are discovered raise new interest in old therapeutics as colchicine and niacin. Biomarker studies call for more specific and sensitive markers. The recent CANTOS trial provided clinicians evidence that directly targeting inflammation by canakinumab is beneficial for the secondary prevention of cardiovascular disease. Whole genome and exome studies will lead to the discovery of new cellular pathways and treatments of residual atherosclerotic inflammation.

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137